RB

Ruby Byahut

Active Director Director DIN 09287958
DIN 09287958 First appointment Aug 2021 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Aug 2021
Shareholding value Locked Premium profile

About Ruby Byahut

Ruby Byahut has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Clinicity Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09287958
Primary Designation Director
First Appointment 20 Aug 2021
Oldest Company Age 4 yrs

Current companies

Company Designation Appointment Founded Status
Clinicity Private Limited U45202WB2021PTC247326
Director 20 Aug 2021 2021 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Clinicity Private Limited
Premium access

Shareholding and investment profile for Ruby Byahut

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ruby Byahut

Ruby Byahut has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Clinicity Private Limited. Engaged in General Business. Contributes to corporate operations.

Ruby Byahut is associated with 1 company as Director.

Ruby Byahut has expertise in General Business.

Ruby Byahut has 4 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available